SMPC in Liposome Formulation: A Guide for Pharmaceutical Developers
In the dynamic field of pharmaceutical development, particularly in the realm of drug delivery systems, phospholipids play a pivotal role. Among these, 1-Stearoyl-2-myristoyl-sn-glycero-3-phosphocholine, commonly known as SMPC, stands out for its specific structural characteristics and broad applicability. As a premium lipid excipient, SMPC is integral to the creation of stable and effective liposomes, a cornerstone technology for delivering a wide range of therapeutics, from mRNA vaccines to potent chemotherapeutics.
SMPC, with its unique combination of a saturated stearic acid (18:0) at the sn-1 position and a saturated myristic acid (14:0) at the sn-2 position, provides specific phase transition temperatures and membrane properties. These characteristics are crucial for controlling the fluidity, stability, and drug release profile of liposomal formulations. Understanding these attributes allows researchers and formulators to tailor liposomes for optimal in vivo performance.
As a leading manufacturer and supplier of high-quality phospholipids, we understand the critical need for purity and consistency in pharmaceutical ingredients. Our SMPC, with a purity of 98% or higher and CAS number 20664-02-2, is manufactured under stringent quality controls. This ensures that it meets the rigorous demands of drug formulation and clinical research. For those looking to buy SMPC for their drug delivery projects, partnering with a reliable supplier like us in China guarantees a stable supply chain and competitive pricing.
The utility of SMPC extends beyond just liposome formation. It is also employed in the preparation of nutritious fat emulsions for injection, underscoring its biocompatibility and safety profile. For pharmaceutical developers, sourcing high-grade SMPC is a critical step in the formulation process. Whether you are developing novel mRNA delivery systems, targeted cancer therapies, or advanced vaccine platforms, the quality of your lipid excipients directly impacts the success of your final product.
We invite you to explore the potential of SMPC in your next project. As your trusted partner, we are committed to providing the essential building blocks for pharmaceutical innovation. Contact us to inquire about pricing, request samples, and learn more about how our premium SMPC can benefit your research and development initiatives.
Perspectives & Insights
Agile Reader One
“As a premium lipid excipient, SMPC is integral to the creation of stable and effective liposomes, a cornerstone technology for delivering a wide range of therapeutics, from mRNA vaccines to potent chemotherapeutics.”
Logic Vision Labs
“SMPC, with its unique combination of a saturated stearic acid (18:0) at the sn-1 position and a saturated myristic acid (14:0) at the sn-2 position, provides specific phase transition temperatures and membrane properties.”
Molecule Origin 88
“These characteristics are crucial for controlling the fluidity, stability, and drug release profile of liposomal formulations.”